Speciality Medicines Ltd

Tue 17/11/2026,16:0:0 | BSE : SPML

₹153.000.00 (0.00%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 153.00

Previous Close

₹ 153.00

Volume

3000

Mkt Cap ( ₹ Cr)

₹ 134.42

High

₹ 153.00

Low

₹ 153.00

52 Week High

₹ 381.20

52 Week Low

₹ 121.10

Book Value Per Share

₹ 81.03

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Speciality Medicines Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Speciality Medicines Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Speciality Medicines - Results-Financial Result For The Half Year Ended On September 30, 2026

    12 Nov 2026, 4:31PM We hereby submit the Standalone Unaudited Financial Result for the half year ended on September 30, 2026
  • Speciality Medicines - Board Meeting Outcome for Outcome Of Board Meeting Held On November 12, 2026 - Financial Result For Th

    12 Nov 2026, 4:26PM We hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on November 12, 2026, at the Corporate Off
  • Speciality Medicines - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday,

    5 Nov 2026, 12:40PM Speciality Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider
  • Speciality Medicines has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    19 Oct 2026, 6:20PM As of September 2026, 43.43% is owned by Indian Promoters and 56.57% by Public. <p align=justify> Top five Promoters holding highest number of shares
  • Speciality Medicines - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    15 Oct 2026, 3:34PM We Hereby Submit the Compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.
  • Speciality Medicines - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    28 Sep 2026, 3:25PM We hereby submit Voting Results and Consolidated Scrutinizer report of the 5th AGM of the Company.
  • Speciality Medicines - Shareholder Meeting / Postal Ballot-Outcome of AGM

    28 Sep 2026, 12:33PM We hereby submit Proceedings of 5th AGM of the Company.
  • Speciality Medicines - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    28 Sep 2026, 3:25PM We hereby submit Voting Results and Consolidated Scrutinizer report of the 5th AGM of the Company.
  • Speciality Medicines - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    28 Sep 2026, 3:25PM We hereby submit Voting Results and Consolidated Scrutinizer report of the 5th AGM of the Company.
  • Speciality Medicines - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    28 Sep 2026, 3:25PM We hereby submit Voting Results and Consolidated Scrutinizer report of the 5th AGM of the Company.
  • Speciality Medicines - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    28 Sep 2026, 3:25PM We hereby submit Voting Results and Consolidated Scrutinizer report of the 5th AGM of the Company.
  • Speciality Medicines - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    28 Sep 2026, 3:25PM We hereby submit Voting Results and Consolidated Scrutinizer report of the 5th AGM of the Company.
  • Speciality Medicines - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    28 Sep 2026, 3:25PM We hereby submit Voting Results and Consolidated Scrutinizer report of the 5th AGM of the Company.
  • Speciality Medicines - Reg. 34 (1) Annual Report.

    3 Sep 2026, 7:45PM We hereby Submit Annual Report of FY 2025-26.
  • Speciality Medicines - Notice Of 5Th Annual General Meeting

    3 Sep 2026, 7:42PM We hereby submit Notice of 5th AGM to be held on September 28, 2026.
  • Speciality Medicines - Board Meeting Outcome for Outcome Of Board Meeting Held On September 03, 2026

    3 Sep 2026, 3:51PM We hereby submit Outcome of the board meeting held on September 03, 2026

Key fundamentals

Evaluate the intrinsic value of Speciality Medicines Ltd stock 

Name March-26 March-25 March-24 March-23
Assets 77.8352 35.4633 17.9222 9.509
Liabilities 77.8352 35.4633 17.9222 9.509
Equity 8.7858 6.4358 5.1168 3.8201
Gross Profit 13.6804 9.0921 5.2608 3.5655
Net Profit 13.0329 8.6082 2.9336 1.6889
Cash From Operating Activities -1.281 -5.7944 -4.8002 -4.2148
NPM(%) 17.31 14.77 10.65 7.26
Revenue 75.2851 58.2714 27.5248 23.2408
Expenses 61.6047 49.1793 22.264 19.6753
ROE(%) 18.3 12.09 4.12 2.37

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Speciality Medicines Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 770.00 -1.91 15.26 87.32 -26.19 0.65
Lotus Eye Hospital and Institute Ltd 103.25 1.03 477.09 318.18 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 9.00 0.11 0.00 660.65 -39.50 0.00
Astec Lifesciences Ltd 561.45 1.33 0.00 340.92 -363.14 0.00

Company Info

Our Company was originally incorporated as "Speciality Medicines Private Limited" as a Private Limited Company, under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre. Later on, pursuant to a special resolution passed by our Shareholders in the ExtraOrdinary General Meeting held on April 04, 2024, our Company was converted from a private limited company to public limited company and consequently, the name of our Company was changed from "Speciality Medicines Private Limited" to "Speciality Medicines Limited" and a fresh certificate of incorporation dated June 25, 2024 was issued to our Company by the Registrar of Companies, Central Registration Centre. The Corporate Identification Number of our Company is U85300GJ2021PLC120022. MAJOR EVENTS:2021- Incorporation of our company viz. "Speciality Medicines Private Limited".- Our Company shifted its operation to Mumbai, Maharashtra, India2022- Our Company was recognized as Start-up by Department for Promotion of Industry and Internal Trade2023- Our Company received certificate as an eligible business by Inter-Ministerial Board to avail Income Tax benefits under Section 80-IAC of the Income Tax Act, 1961.2024- Conversion of our Company from Private Limited to Public Limited Company.

Our Company was originally incorporated as "Speciality Medicines Private Limited" as a Private Limited Company, under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre. Later on, pursuant to a special resolution passed by our Shareholders in the ExtraOrdinary General Meeting held on April 04, 2024, our Company was converted from a private limited company to public limited company and consequently, the name of our Company was changed from "Speciality Medicines Private Limited" to "Speciality Medicines Limited" and a fresh certificate of incorporation dated June 25, 2024 was issued to our Company by the Registrar of Companies, Central Registration Centre. The Corporate Identification Number of our Company is U85300GJ2021PLC120022. MAJOR EVENTS:2021- Incorporation of our company viz. "Speciality Medicines Private Limited".- Our Company shifted its operation to Mumbai, Maharashtra, India2022- Our Company was recognized as Start-up by Department for Promotion of Industry and Internal Trade2023- Our Company received certificate as an eligible business by Inter-Ministerial Board to avail Income Tax benefits under Section 80-IAC of the Income Tax Act, 1961.2024- Conversion of our Company from Private Limited to Public Limited Company.

Parent Organisation

Speciality Medicines Ltd.

Founded

05/02/2021

Managing Director

Mr.Parthkumar Goyani

NSE Symbol

FAQ